07-02-2004: LANXESS, the future company where the Bayer Group will combine almost all areas of its chemicals business and parts of its polymers activities, began operating as an independent unit on July 1, 2004.For the moment the new structure only applies internally. "We've reached an important milestone for the realignment of the Group on schedule," said Chairman of the Bayer Board of Management Werner Wenning. LANXESS will be able now to operate largely independently, he said. The company is scheduled to be listed on the stock exchange at the beginning of 2005. And the decision as to whether this will take place via an IPO or a spin-off will be taken over the coming weeks. Until the stock market flotation, LANXESS will operate under the umbrella of the Bayer AG holding company.
Bayer will in future concentrate its resources on the innovative areas of health care, nutrition and high-quality materials and thus establish a sound basis for sustainable growth. "I'm convinced that both companies will enjoy considerable success in the future," said the Bayer CEO.
With sales of around EUR 6 billion and around 20,000 employees, of whom approx. 11,000 are in Germany, LANXESS will be one of the leading chemicals companies in Europe. And after the planned stock market flotation it will operate as an independent company with its own business model, thereby enabling it to react faster and more flexibly on the market.
Dr. Axel C. Heitmann, designated LANXESS CEO, is fully satisfied with the progress of the carve-out process so far. In just over half a year, the activities of Bayer Chemicals and Bayer MaterialScience transferred to LANXESS and parts of the service companies have been molded together to form a new organization. "What we have to do now is use our strengths to their full advantage so as to achieve a competitive result and to ensure LANXESS a smooth transition to becoming an independent company outside the Bayer Group," he said. "That's why it's still important to seize every single possibility for cutting costs and grasp every new market opportunity."
Despite a 2.1 percent decline in sales to EUR 1.478 billion (2.2 percent up in local currencies), the consolidated business results for LANXESS in 1Q 2004 showed a 5.4 percent improvement in EBITDA to EUR 136 million. Compared to 1Q 2003, the EBIT grew by EUR 58 million to EUR 75 million.
Watchlist
This is where you can add this news to your personal favourites
Bayer's commitment to sustainability has gained special recognition: At the World Economic Forum in Davos, the rating agency SAM and the auditors KPMG presented their Sustainability Yearbook 2012, which named Bayer as the best German chemical company and one of only three enterprises in the ... more
Bayer MaterialScience has begun construction of a multipurpose production plant for polyurethane coating raw materials at Chempark Leverkusen. The products hexamethylene diisocyanate (HDI) and isophorone diisocyanate (IPDI) are used primarily for high-quality and environmentally friendly au ... more
Bayer MaterialScience has commissioned a new technical center for the development of isocyanate production processes at Chempark Dormagen. The research center was erected in just under a year with an investment of EUR 5 million.
“All global research activities related to the production of a ... more
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more
LANXESS is continuing to expand its Indian production site in Jhagadia, Gujarat state. The specialty chemicals group is underlining its commitment to the subcontinent by inaugurating three new plants this month to serve the growing India market. LANXESS has invested over EUR 70 million and ... more
The German specialty chemicals group LANXESS is focusing on the megatrend of mobility on the Russian market too. At its new site in Lipezk, LANXESS subsidiary Rhein Chemie will produce rubber additives and release agents for the Russian and CIS markets, especially for the automotive and tir ... more
The governments of both countries have declared the period from mid-2011 to mid-2012 as the “German-Indian” year. Federal Chancellor Angela Merkel opened the celebrations on a journey to Indian last year, when she visited New Delhi. Indian is also currently a point of focus for LANXESS. At ... more
LANXESS is Germany’s largest listed specialty chemicals group and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps it ... more
LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more
LANXESS Sybron Chemicals Inc., provides world-class ion exchange resins to meet the needs of numerous applications. The global strength of Lewatit ion exchange resins in industrial water and chemical processing markets is joined with the solid position Ionac ion exchange resins enjoy in the ... more